Immutep

IMMPNasdaq Australia Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$56.787 M

$0.39 +2.85%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#344Xilio TherapeuticsXLO$60.3M
#345IntercureINCR$58.0M
#346ImmutepIMMP$56.8M
#347Stablecoin DevelopmentSDEV$52.1M
#348ScynexisSCYX$52.0M

Where these numbers come from

Share counts and financials for Immutep are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.